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Cardiac myosin binding protein C (cMyBP-C) has a key regulatory role
in cardiac contraction, but the mechanism by which changes in
phosphorylation of cMyBP-C accelerate cross-bridge kinetics remains
unknown. In this study, we isolated thick filaments from the hearts of
mice in which the three serine residues (Ser273, Ser282, and Ser302)
that are phosphorylated by protein kinase A in the m-domain of
cMyBP-C were replaced by either alanine or aspartic acid, mimicking
the fully nonphosphorylated and the fully phosphorylated state of
cMyBP-C, respectively. We found that thick filaments from the
cMyBP-C phospho-deficient hearts had highly ordered cross-bridge
arrays, whereas the filaments from the cMyBP-C phospho-mimetic
hearts showed a strong tendency toward disorder. Our results
support the hypothesis that dephosphorylation of cMyBP-C promotes
or stabilizes the relaxed/superrelaxed quasi-helical ordering of the
myosin heads on the filament surface, whereas phosphorylation
weakens this stabilization and binding of the heads to the backbone.
Such structural changes would modulate the probability of myosin
binding to actin and could help explain the acceleration of cross-
bridge interactions with actin when cMyBP-C is phosphorylated
because of, for example, activation of β1-adrenergic receptors in
myocardium.
cMyBP-C | cardiac myosin binding protein C | cardiac thick filament | cardiac
thick filament structure | cardiac myosin binding protein C function
Myosin binding protein C is a major accessory protein as-sociated with myosin in the vertebrate thick filament (1).
The importance of the cardiac isoform of MyBP-C (cMyBP-C) in
myocardial contraction is indicated by evidence that mutations in
its encoding gene (MYBPC3) are a major cause of familial hy-
pertrophic cardiomyopathy (2, 3). Further evidence from studies
using biochemical extraction, genetic ablation, and phosphoryla-
tion of cMyBP-C has demonstrated that it is a major regulator of
cross-bridge kinetics and myocardial contraction (4–12).
cMyBP-C is located at nine sites 42.9-nm apart along a portion
of the cross-bridge region in each half of the cardiac thick fila-
ment (13): the C-zone (14, 15). The protein consists of 11 re-
peating fibronectin-like and Ig-like domains, labeled C0 to C10,
from the N terminus to the C terminus (10, 16, 17), with binding
sites for both myosin S2 and F-actin at its N terminus (18–23)
and sites for binding to light meromyosin and titin at its C ter-
minus (24, 25). Its regulatory role is mediated by an m-domain
or m-motif that lies between the C1 and C2 domains. This re-
gion has four serines that are phosphorylated in response to
β-adrenergic agonist stimulation of living myocardium (10, 19,
26–31). Three of these sites are principally phosphorylated by
protein kinase A (PKA) (10), whereas the fourth is principally
phosphorylated by Ca2+-calmodulin–dependent kinase (CAMK)
(10, 32). When nonphosphorylated, binding of this region and
associated N-terminal domains to both the S2-region of myosin
(10, 19, 21, 22, 33, 34) and F-actin (35–45) have been demon-
strated. Phosphorylation of this region, in contrast, abolishes
binding to myosin S2 and weakens the binding to F-actin (10, 20,
38, 46, 47).
These data are consistent with a mechanism in which cMyBP-
C in the nonphosphorylated state normally depresses cross-
bridge kinetics and its interaction with the thin filament, whereas
phosphorylation of cMyBP-C accelerates cross-bridge kinetics
and increases the interactions of myosin with the thin filament
(reviewed in ref. 48). However, the precise molecular mechanism
by which this occurs remains an enigma. Because cMyBP-C has
binding sites for both myosin S2 and F-actin, regulation of
contraction by cMyBP-C could involve its binding to myosin S2,
F-actin, or both.
Although much of the recent work on cMyBP-C has focused
on its ability to bind to F-actin (35–45) as a possible regulatory
mechanism, reversible phosphorylation-dependent binding of
the N-terminal region of cMyBP-C to the S2-region of myosin
(10, 20–23, 33, 34, 49) or to other regions of myosin (50, 51) also
remains a strong possibility as a mechanism by which cMyBP-C
could regulate contraction.
Consistent with such a mechanism, several studies have im-
plicated phosphorylation-regulated binding of the N-terminal
region of cMyBP-C to the S2 region of myosin, with correlated
changes in thick filament structure, and its binding to the thin
filament, as either an additional or alternative mechanism for
regulation of cross-bridge kinetics and contraction by cMyBP-C
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(10, 19–22, 52–54). Support for regulation involving binding of
cMyBP-C to the S2-region of myosin is provided by studies
showing that mutations in myosin S2 which produce familial
hypertrophic cardiomyopathy (HCM) may abolish the in-
teraction with the regulatory domain of myosin-binding protein-
C (19). Similarly, it has been demonstrated that the E258K
HCM-causing mutation in cMyBP-C abolishes interaction between
the N terminal of cMyBP-C and myosin-S2 by directly disrupting
the cMyBP-C–S2 interface independent of cMyBP-C phosphoryla-
tion (49). This disruption accelerates contractile kinetics (49), sim-
ilar to the effects of ablation of cMyBP-C or phosphorylation. In
addition, the results of Calaghan et al. (33), showing that exogenous
S2 when added to myofibrils affects their contractile properties, also
appear to support a role for the binding of cMyBP-C to myosin S2
as part of the regulatory mechanism. This binding could act as a
tether of the myosin head to the filament backbone or stabilize the
relaxed cross-bridge array, thus constraining the cross-bridge ki-
netics. For example, the interaction of cMyBP-C with the S2 region
of myosin is abolished upon phosphorylation (20), which may free
the tether or change the properties of the myosin head to allow
faster cross-bridge kinetics (6, 8, 49). Similarly, recent studies
showing that the C0 domain of cMyBP-C may bind to the regula-
tory light chain (50), or possibly to the mesa region of the myosin
head (51), are consistent with a regulatory mechanism in which
binding of cMyBP-C to myosin could affect the spatial arrangement
of myosin heads on the thick filament and their interactions with the
thin filament.
Although earlier studies have examined the effect of phos-
phorylation of cMyBP-C on the cross-bridge arrangement in
isolated rat cardiac thick filaments (52–54), the extent of phos-
phorylation of cMyBP-C for the individual filaments examined in
the electron microscope was unknown in these studies. This
finding, along with our more recent results from cMyBP-C
knockout cardiac thick filaments (55, 56), which appear to differ
from the earlier results for the isolated rat cardiac thick fila-
ments, has left open questions about the effect of phosphoryla-
tion of cMyBP-C on cross-bridge arrangement.
Because the levels of phosphorylation of cMyBP-C in the wild-
type filaments can be variable, to determine directly the impact of
cMyBP-C phosphorylation on the arrangement of cross-bridges on
the thick filament, we have compared the structure of cardiac
thick filaments from previously generated transgenic mouse
lines cMyBP-C(t3SA) and cMyBP-C(t3SD), in which the three
m-domain serine residues (Ser273, Ser282, and Ser302) that are
phosphorylated by PKA were replaced by either alanine or aspartic
acid, respectively, to mimic the nonphosphorylated or the phos-
phorylated states of cMyBP-C (9, 29–31). For brevity, we will refer
to these as the CT-SA and CT-SD mouse lines, respectively.
These transgenic mice have been well characterized as models
for the nonphosphorylated and phosphorylated states of cMyBP-C
(9, 29–31) and the effects of phosphorylation on the kinetics of
cardiac contraction (reviewed in ref. 48). The modified proteins
have been demonstrated by immunofluorescence to properly in-
corporate into the myofibril (9, 31), with expression levels of 74%
(CT-SA) and 84% (CT-SD) (31) relative to true wild-type. Be-
cause the mutations were produced in mice with a null-back-
ground, 100% of the cMyBP-C is mutated (9, 29–31) and
endogenous cMyBP-C is absent. Western blots have verified that
the serine residues (Ser273, Ser282, and Ser302) in the cMyBP-C
of the CT-SA myocardium, unlike wild-type myocardium, are
nonphosphorylated under both basal conditions and in the pres-
ence of dobutamine (29), thus establishing CT-SA myocardium as
a good model for studying the functional and structural role of
cMyBP-C in the nonphosphorylated state. Similarly, the CT-SD
myocardium has comparable contractile properties to those pro-
duced by PKA phosphorylation or ablation of cMyBP-C (31, 48).
Thus, these transgenic mice provide a unique, well-characterized
model system in which cMyBP-C is present on all of the isolated
filaments and the phospho-mimetic state of cMyBP-C on each thick
filament is known. Our results show that thick filament structural
effects caused by mimicked phosphorylation in the CT-SD mouse
filaments are virtually identical to those we previously obtained
from the cMyBP-C knockout mouse hearts (55, 56), where we
demonstrated that the absence of cMyBP-C results in a tendency
toward disorder of the myosin heads. The filaments from the CT-
SA mouse hearts appeared well ordered and similar to well-ordered
wild-type filaments isolated by the same procedure. These results
provide a compelling structural basis for recent results and models
(48, 57, 58), suggesting that nonphosphorylated cMyBP-C stabilizes
the relaxed highly ordered off-state configuration of the thick fila-
ment. Moreover, it is now even more evident that models of the
regulation of contraction via phosphorylation of cMyBP-C must
involve modulation of its interactions with myosin.
Results
Appearance of the Filaments. Thick filaments were isolated from
both the CT-SA and CT-SD mouse hearts and their structures
compared. Filaments from wild-type mouse hearts isolated in
parallel using the same procedure appeared similar in structure
to those we have previously described (55, 56). As shown in the
low-magnification electron micrographs in Figs. 1A and 2A, the
thick filaments from both the CT-SA and CT-SD mouse hearts
appear normal, with a length of ∼1.6 μm and a bipolar structure
with a central bare zone (asterisks in Figs. 1A and 2A) similar to
that of the wild-type mouse cardiac thick filaments and to the
structure previously shown for vertebrate cardiac thick filaments
(55, 56, 59–63). The measured diameters for both the CT-SA and
CT-SD filaments were very similar to each other: 31.1 ± 1.6 nm
(mean ± SD, n = 597 measurements from 60 filaments) for the
CT-SA filaments and 31.0 ± 1.8 nm (n = 581 measurements from
60 filaments) for the CT-SD filaments. This finding is very sim-
ilar to the diameters of 31.0 ± 1.7 nm and 31.1 ± 1.4 nm, which
we reported previously for wild-type and cMyBP-C knockout
cardiac thick filaments (55). Histograms of the distributions of
diameters of both the CT-SA and CT-SD filaments were unim-
odal (Fig. S1), suggesting single populations of filaments for
each preparation.
Despite the similarity in their length, diameter, and bipolar
structure to control wild-type filaments, differences between the
CT-SA and CT-SD cardiac filaments were apparent in the extent
of order versus disorder of their cross-bridge arrangements.
As shown in Fig. 1, the thick filaments from CT-SA mouse
hearts, in which the nonphosphorylated state of cMyBP-C is mim-
icked by replacement of serines with nonphosphorylatable alanines,
typically appear very periodic with well-ordered arrangements of the
myosin heads. This is apparent both in the low-magnification
electron micrograph of a field of the filaments (Fig. 1A) and in the
higher-magnification gallery of images of straightened individual
filaments (Fig. 1 B–E). Both the quasi-helical paths of the myosin
heads and the 42.9-nm axial periodicity (indicated by the black bars
in Fig. 1 B–E) are clearly evident along the cross-bridge regions of
the filaments in the form of the “saw-tooth” staining pattern of the
cross-bridge array, which we have previously shown for other ver-
tebrate striated muscle thick filaments (55, 59, 62). This saw-tooth
staining pattern is illustrated in Fig. 1E, in which the periodic
Fourier layer-line filtered image of the cross bridge arrangement of
that filament was overlaid on the micrograph image. This periodic
staining pattern, as we have previously shown (62), results from
the well-ordered three-stranded quasi-helical arrangement of the
myosin heads on the filament. It can be clearly seen in the
bracketed region of the filament at low magnification in Fig. 1A
and in all of the other filaments (Fig. 1 A–D) as well. The ordered
CT-SA filaments thus appear very similar to the examples of well-
ordered wild-type mouse cardiac thick filaments previously de-
scribed (55, 56), and to control wild-type filaments observed in
the current study (Fig. S2). In contrast, as shown in Fig. 2, the
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filaments from the CT-SD hearts, with the mimicked fully phos-
phorylated state of cMyBP-C were much more variable in their
periodicity. Although we were able to find some filaments that
appeared relatively well-ordered and maintained the expected
42.9-nm quasi-helical periodicity, most of the CT-SD filaments
appeared much more disordered in their cross-bridge arrange-
ment compared with the CT-SA filaments. Typically, most of the
filaments retained some evidence of the 42.9-nm quasi-helical
arrangement of the cross-bridges along their cross-bridge regions,
but looked “ragged” and disordered compared with the filaments
from the CT-SA hearts. Often the CT-SD filaments had short
regions of partial order (brackets in Fig. 2) with the saw-tooth
pattern of staining of the myosin heads discernible, whereas the
rest of the filament was much more disordered.
Thus, the CT-SD filaments, although they can be well-
ordered, appear to show a much stronger tendency toward
disorder of the cross-bridges compared with the filaments from
the CT-SA hearts (compare Figs. 1 and 2, and Fig. S2). This
result is similar to our previous observations of isolated fila-
ments from cMyBP-C knockout mouse cardiac thick filaments
(55, 56), which also showed a greater tendency toward disorder
of the heads compared with the wild-type filaments with
cMyBP-C present.
There were slight differences in the number of well-ordered
filaments present in the multiple filament isolations we carried
out for both the CT-SA and CT-SD hearts; however, this dis-
tinction between the CT-SA cardiac thick filaments and the CT-
SD filaments was quite reproducible.
Assessment of Filament Periodicity with Fourier Transforms. Fourier
transform analysis of the C-zone region of images of the fila-
ments isolated from the CT-SA and CT-SD mouse hearts con-
firmed the visual assessment of the degree of order of the myosin
head array in each of the filament groups (Figs. 3 and 4).
Large numbers of the filaments from the CT-SA mouse hearts
gave Fourier transforms with a strong set of sharp layer lines
extending to at least the 11th or 12th meridional reflections of
the thick filament quasi-helical 42.9-nm periodicity of the myosin
heads (Fig. 3). The transforms from the individual CT-SA fila-
ments (Fig. 3 A–D) were consistent with those we have pre-
viously shown for well-ordered wild-type mouse cardiac thick
filaments (55, 56). A strong set of off-meridional layer lines
corresponding to the quasi-helical arrangement of the myosin
heads was present up to the sixth layer line. Strong meridional
reflections corresponding to the 14.3-nm average axial spacing of
the cross-bridge levels were generally present on the 3rd and 6th
layer lines, and occasionally on the 9th and 12th layer lines as
Fig. 1. Electron micrograph images of the isolated and negatively stained thick filaments from the CT-SA mouse hearts. (A) Lower-magnification image of a
field of the isolated thick filaments from the CT-SA hearts. The bipolar structure of the filaments with a central bare zone (asterisks) is apparent and consistent
with previous images of isolated mouse cardiac thick filaments. Even at this lower magnification, the well-ordered periodic appearance of the thick filaments
is apparent. The bracket marks a region of a filament in which the distinctive saw-tooth staining pattern of the myosin heads on the filament shown in the
Fourier-filtered image of a filament in E is apparent. (B–D) A gallery of higher-magnification images of the individual CT-SA filaments is shown. The individual
images were straightened using the straightening function in ImageJ for better comparison. The cross-bridge regions of the filaments are well ordered with
the 42.9-nm axial periodicity of the myosin head array indicated by the black tick marks. (E) The Fourier transform filtered image of the filament obtained
using the first six layer lines of the transform is shown overlaid on the micrograph of the filament. It illustrates the distinctive saw- tooth pattern of staining of
the myosin cross-bridge array, which we have previously described, and which can also be seen in the aligned filament images in B–D. The black bars at the
bottom right hand corner of the micrographs indicate the scale.














well. The “forbidden” meridional reflections (reflections not
expected from helical symmetry) previously shown both in X-ray
diffraction patterns of living skeletal (64) and heart (65) muscle
and in transforms of other isolated vertebrate striated muscle
thick filaments, including mouse cardiac thick filaments (55, 56,
61–63), were frequently present on the 1st, 2nd, 4th, 5th, 8th,
10th, and 11th layer lines. These features of the transforms, in-
dicating the highly ordered structure of the filaments, were
particularly evident in an average of 10 transforms from indi-
vidual CT-SA filaments (Fig. 3E). This averaged transform can
extend to at least the 12th layer line of the 42.9-nm axial peri-
odicity, suggesting that the periodicity in the CT-SA filaments
extends to at least 3.58 nm.
The individual Fourier transforms from the CT-SD filaments in
contrast were much more variable (Figs. 4 A–D). Although some
of the filaments yielded transforms with sets of off-meridional
layer lines and meridional reflections similar to those seen in the
well-ordered CT-SA filaments (Fig. 4 A and B), many of the fil-
aments gave transforms with only weak or diffuse off-meridional
layer lines, even on the first and second layer lines (Fig. 4 C and
D), which are the strongest in the CT-SA filaments. The presence
of the meridional reflections on both the third and sixth layer lines
was consistent with preservation of the average 14.3-nm spacing of
the cross-bridge density on the filaments. Thus, the weakness and
the diffuse nature of the reflections on the off-meridional layer
lines in many of the transforms from the CT-SD filaments most
likely results from disorder of the myosin heads along the quasi-
helical paths on the filament. This finding is consistent with the
filament images showing a tendency toward disorder of the myosin
heads in the CT-SD filaments. Overall, a much smaller percentage
of the filaments from the CT-SD mouse hearts gave strong
transforms indicative of a well-ordered array of the myosin heads,
compared with the filaments from the CT-SA mouse hearts.
The general weakness in the layer line pattern of the trans-
forms from the individual filaments from the CT-SD hearts was
also apparent in the transform obtained by averaging 10 of the
best transforms from the CT-SD cardiac filaments (Fig. 4E).
Although this averaged transform showed a similar set of layer
lines to that seen in the CT-SA transforms, the pattern of the off-
meridional layer lines was weaker and the layer line reflections
more diffuse than seen for the averaged transform of the CT-SA
filaments (Fig. 3E). The layer lines of the averaged CT-SD
transform appeared to extend to a lower radius from the me-
ridian with weaker subsidiary maxima and a more rapid fall-off in
intensity of the maxima compared with the transform from the
CT-SA filaments (Figs. 3 and 4 and Fig. S3). This finding was
confirmed in measurements of individual transforms of the
CT-SD and CT-SA filaments where periodic information on the
first layer line extended to only 8.4 ± 1.6 nm−1 (mean ± SD, n = 50
transforms) resolution for the CT-SD transforms compared with
6.5 ± 0.9 nm−1 (n = 50 transforms) resolution for the CT-SA
transforms, the larger SD for the CT-SD transforms reflecting the
greater variation in these transforms.
These results are consistent with our observation that although
the CT-SD filaments retained the 42.9-nm pseudohelical period-
icity in some filaments and along short regions of other filaments,
overall the filaments appeared much more prone to disordering of
Fig. 2. Electron micrograph images of the isolated and negatively stained thick filaments from the CT-SD mouse hearts. (A and B) Lower-magnification and
higher-magnification images of fields of the isolated filaments from the hearts of the CT-SD mice. Compared with the filaments from the CT-SA hearts, the
CT-SD filaments typically appear much more disordered, as seen in both panels. Although the 42.9-nm axial periodicity can still be recognized, particularly in
regions, such as those indicated by the black brackets, many areas of the filaments appear to have at least partial disordering of the myosin head array.
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the arrangement of the myosin heads compared with the filaments
from the CT-SA mouse hearts.
One interesting feature of the transforms from the CT-SD
filaments was the relatively strong intensity of the “forbidden”
meridional reflections, particularly those on the first and second
layer lines, compared with the CT-SA filaments (Fig. 3) and to
transforms of the cMyBP-C knockout cardiac thick filaments, in
which these reflections were weak or absent (55). A possible
explanation for this finding is that the disorder of the heads is
exposing periodic structure along the backbone, such as the
density of the C8-C10 domains of cMyBP-C which are present
axially every 42.9 nm, or that cMyBP-C has changed to a con-
formation more perpendicular to the thick filament axis,
strengthening its contribution to the 42.9-nm meridional reflec-
tion. In the earlier case of the cMyBP-C knockout filaments,
cMyBP-C was absent and could not contribute intensity to
these reflections.
Discussion
In this study, we examined the structure of isolated thick filaments
from mice in which the nonphosphorylated and phosphorylated
states of cMyBP-C are mimicked by amino acid substitutions of
either alanine or aspartic acid for the PKA-phosphorylatable serines
in the m-domain (9, 29–31). As described at the beginning of this
report, both the phospho-deficient CT-SA [cMyBP-C(t3SA)] and
phospho-mimetic CT-SD [cMyBP-C(t3SD)] transgenic mouse heart
models studied here have been well characterized in their physio-
logical properties and differences, including protein expression,
proper insertion into the myofibril, and inability of the PKA-phos-
phorylatable serines in the m-domain to be phosphorylated in the
CT-SA mouse hearts (9, 29–31). Basal levels of phosphorylation of
the regulatory light chain (RLC), which has been shown to affect
the cross-bridge order in skeletal muscle (66) and the radius of the
cross-bridge in cardiac muscle (67), has been demonstrated to be
similar (∼40%) for both the CT-SA and CT-SD mouse hearts (29,
31). This finding, together with the report by Chang et al. (68) that
the phosphorylation levels of mouse cardiac RLC are not main-
tained, but rapidly decrease in homogenates and isolated filament
preparations, means that RLC phosphorylation levels should be
similar and very low (∼10%) in our filament preparations. Thus,
differences in phosphorylation levels of RLC cannot explain dif-
ferences seen between the filaments from the CT-SA and CT-SD
hearts. These cMyBP-C mutant mice thus provide a unique model
system for the study of the effects of dephosphorylation and phos-
phorylation of cMyBP-C, both for physiological studies of contrac-
tile kinetics (reviewed in ref. 48) and for structural studies such as
reported here.
We found that the thick filaments from the hearts of the CT-SA
mice, which mimic the nonphosphorylated state of cMyBP-C, typ-
ically maintained the well-ordered pseudohelical relaxed arrange-
ment of the myosin heads previously shown for relaxed vertebrate
cardiac thick filaments (55, 56, 59–63). The thick filaments from the
Fig. 3. Fourier transforms of the thick filaments isolated from the CT-SA mouse hearts. (A–D) A gallery of Fourier transforms computed from images of
regions along the arms of individual thick filaments isolated and negatively stained from the CT-SA mouse hearts. The transforms show a strong set of layer
lines corresponding to the 42.9-nm axial repeat of the myosin heads out to at least the sixth layer line (indicated by numbered tick marks on the side; EQ is the
equator of the pattern). The transforms confirm the highly ordered arrangement of the myosin heads on the CT-SA filaments with cMyBP-C unable to be
phosphorylated. (E) Fourier transform obtained by averaging 10 of the Fourier transforms obtained from the individual CT-SA thick filaments. The transform
shows layer lines extending to at least the 12th order of the 42.9-nm axial repeat of the pseudohelical arrangement of the myosin heads on the filament. The
boxed and lightened region shows the meridional reflections on the layer lines beyond the strong inner six layer lines. This transform clearly shows that the
filaments from the CT-SA mouse hearts with nonphosphorylated cMyBP-C are very well ordered.














CT-SD mouse hearts, which mimic the phosphorylated state of
cMyBP-C, showed a much stronger tendency toward disorder of the
myosin heads.
Comparison with Earlier Studies. These results, like those of our
earlier studies of the cMyBP-C knockout mouse cardiac thick fila-
ments (55, 56), were surprising because they differed from previous
results reported by Weisberg and Winegrad (52, 53) and Levine
et al. (54) for the effects of phosphorylation of cMyBP-C on the
cross-bridge arrangement in isolated rat cardiac thick filaments.
The studies of Weisberg and Winegrad (52, 53) reported that
phosphorylation of cMyBP-C produced an increase both in the
cross-bridge order of the filament and in the diameter of isolated
rat cardiac thick filaments. Consistent with this, Levine et al. (54)
presented data supporting a model in which the cross-bridge array
on the filament was disordered when cMyBP-C was non-
phosphorylated and that upon phosphorylation of cMyBP-C, the
myosin array on the thick filament changed from disordered to a
highly ordered array with expansion of the filament diameter,
extension of the myosin heads, and loosening of the backbone
structure. It was further proposed that upon phosphorylation of
cMyBP-C, the cross-bridges were less flexible and that the loos-
ening of the backbone would be associated with an increase in
diameter of a collar-like structure formed by the three cMyBP-C
molecules present at every third cross-bridge level (69, 70).
Although the Levine et al. (54) model is widely cited as a
mechanism by which cMyBP-C phosphorylation regulates contrac-
tion, one major ambiguity in these studies is that the actual state of
phosphorylation of cMyBP-C for any individual filament examined
in the electron microscope was unknown. The degree of phos-
phorylation was measured for the whole population of filaments
and not the individual filaments that were examined. Thus, a direct
correlation of the degree of cross-bridge order for a filament and
the state of phosphorylation of its cMyBP-C was not possible.
Our subsequent studies comparing the structure of thick fila-
ments isolated from cMyBP-C knockout mouse hearts to those
isolated from wild-type hearts (55, 56) raised some questions
about this model. The absence of cMyBP-C on the thick fila-
ments in the knockout mouse could be argued to be analogous to
the phosphorylated state of cMyBP-C, because in both cases the
interaction of cMyBP-C with myosin S2 would be weakened or
abolished (20). Interestingly, the cardiac filaments from the
cMyBP-C knockout mouse hearts showed no difference in di-
ameter from the wild-type filaments and showed a strong ten-
dency to have a disordered cross-bridge array, not the increased
diameter and increased cross-bridge order predicted by the
Fig. 4. Fourier transforms of the thick filaments isolated from the CT-SD mouse hearts. (A–D) A gallery of Fourier transforms computed from images of
regions along the arms of individual thick filaments isolated and negatively stained from the CT-SD mouse hearts. Although the transforms showed that most
of the CT-SD filaments retained some of the pseudohelical arrangement of the heads, only a few filaments gave strong transforms (A and B) with a sharp set
of off-meridional layer lines extending to at least the sixth layer line (indicated by numbered tick marks on the side; EQ is the equator of the pattern) similar
to that seen in the CT-SA filaments. Many of the CT-SD filaments gave transforms (C and D) in which the inner layer lines—particularly the first and second—
were often blurred or absent, suggesting disorder of regions of the myosin heads on the filaments. (E) An averaged Fourier transform obtained by averaging
10 of the Fourier transforms obtained from the individual CT-SD thick filaments. As in the case of the averaged transform obtained from the CT-SA filaments,
layer lines can be recognized out to approximately the 12th layer line. However, the layer lines were found to be weaker, blurred, and poorly defined
compared with the averaged transform from the CT-SA filaments, again consistent with increased disorder of the myosin heads. The lower radial extent of
the layer lines is also consistent with a lower resolution of the periodic information. The boxed and lightened region shows the meridional reflections on the
layer lines beyond the strong inner six layer lines.
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studies of Levine et al. (54). These results were found both in a
study by Kensler and Harris (55) and a separate study by Zoghbi
et al. (56). One caveat to these results, however, was the question
whether the genetic ablation of cMyBP-C and phosphorylation
of cMyBP-C are entirely analogous, although both have similar
physiological effects (reviewed in ref. 48).
In contrast to the earlier studies by Weisberg andWinegrad (52,
53) and Levine et al. (54), in the present study of filaments from
the cMyBP-C phospho-deficient CT-SA and the cMyBP-C phos-
pho-mimetic CT-SD mutant mouse hearts, the state of pseudo-
phosphorylation of cMyBP-C is known for each examined filament
(9, 29–31). With the change from serine to alanine for each of the
three PKA-phosphorylatable serines in the m-domain of cMyBP-C
in the CT-SA mouse hearts, the cMyBP-C molecules cannot be
phosphorylated at these sites and should be analogous to the
completely nonphosphorylated state of cMyBP-C (9, 29, 31).
Similarly, the substitution of aspartic acid for the serines in the
cMyBP-C in CT-SD hearts should mimic the fully phosphorylated
state of the cMyBP-C (30, 31). This idea is supported by evidence
that the cMyBP-C phosphomimetic mice exhibit physiological
effects on contractile kinetics very similar to those reported in
earlier studies using ablation of cMyBP-C or PKA-induced
phosphorylation of cMyBP-C (reviewed in ref. 48). In addition,
unlike the cMyBP-C knockout mouse hearts, cMyBP-C is still
present on the filaments of both the CT-SA mouse hearts and the
CT-SD mouse hearts.
The results for the filaments isolated from the CT-SA mouse
hearts are particularly striking because the three serines in the
m-domain of cMyBP-C, which can normally be phosphorylated
by PKA, are completely nonphosphorylatable. In contrast to the
Levine et al. (54) model, which would predict that these fila-
ments with completely nonphosphorylated cMyBP-C should be
highly disordered in their cross-bridge arrangement, these fila-
ments tend to be very well ordered. Similarly, the filaments from
the hearts of the CT-SD mice, which should mimic the fully
phosphorylated state of the cMyBP-C, would have been pre-
dicted by the Levine et al. (54) model to be very well ordered, but
were found instead to have a strong tendency toward disorder of
the myosin heads. This disorder of the heads in the filaments of
both the CT-SD mouse hearts and the filaments from the
cMyBP-C knockout mouse hearts suggests that the myosin heads
are likely less tightly bound to the backbone and perhaps more
mobile, not less flexible or less free to move, as suggested by
Levine et al. (54).
Interestingly, in contrast to the results of Weisberg and Wine-
grad (52, 53) and Levine et al. (54), we did not see a significant
change in diameter of either the filaments from the CT-SD (31.0 ±
1.8 nm) or CT-SA filaments (31.1 ± 1.6 nm) from the wild-type
diameter of 31.0 ± 1.7 nm we reported previously (56). Histo-
grams of the filament diameter distributions for the CT-SA and
CT-SD filaments (Fig. S1) show similar unimodal distributions of
the diameters. In the earlier results by Weisberg and Winegrad
(52, 53) and Levine et al. (54), it was reported that the filaments
with phosphorylated cMyBP-C were highly ordered and had a
diameter of 36–37 nm, greater than the 30–32 nm found for the
filaments with nonphosphorylated cMyBP-C. We did not observe
this increase in either diameter or cross-bridge order for the
CT-SD filaments, which should have corresponded to the fila-
ments with phosphorylated cMyBP-C observed by Weisberg and
Winegrad (52, 53) and Levine et al. (54). Instead, the results
complement our previous observations demonstrating that
cMyBP-C knockout heart filaments did not differ significantly in
diameter from the wild-type filaments (55), but showed a greater
tendency toward disorder.
The reason for the difference between the earlier studies by
Weisberg and Winegrad (52, 53) and Levine et al. (54) for iso-
lated rat cardiac thick filaments and our studies of the isolated
thick filaments from cMyBP-C knockout mouse hearts (55, 56)
and the phosphomimetic mouse hearts is not certain. However,
there are several differences between our studies and theirs. In
addition to knowing the mimicked state of phosphorylation of
cMyBP-C for each filament in our studies of the mutant mice, we
also used the 42.9-nm axial periodicity of the thick filaments as
an internal ruler for the measurements of filament diameter, in
both our earlier measurements of the diameter of the wild-type
and cMyBP-C mouse heart filaments (55) and in the filaments
from the phosphomimetic mice reported here. This avoided
possible differences in magnification in the electron microscope
from day to day, which can affect measurements of the apparent
diameter of the filaments. In addition, the use of Fourier
transforms in our studies, rather than the optical diffraction
patterns used in their studies (52–54), has allowed us to more
easily assess the extent of order of the filaments. The averaging
of the transforms, in both our previous cMyBP-C knockout
cardiac filament studies (55) and the studies here of the phos-
phomimetic mouse heart filaments, provides a particularly useful
tool for assessing the order of a population of filaments that is
not available with optical diffraction. Furthermore, many of the
optical diffraction patterns used in the earlier studies of the
isolated rat cardiac thick filaments (52–54) were relatively weak,
with only one or two strong off-meridional layer lines, thus
making it difficult to assess the extent of order of the filaments in
those studies.
Interpretation of Results for the CT-SA and CT-SD Thick Filaments.
Our previous results from studies of cMyBP-C knockout mice
(55, 56) provided evidence that, although cMyBP-C is not a re-
quirement for maintenance of the highly ordered relaxed state of
the myosin heads, it may help to stabilize that order. The results
from the current study of cMyBP-C phosphomimetic mouse
cardiac thick filaments add to this conclusion by showing that
when nonphosphorylated, cMyBP-C stabilizes and promotes the
relaxed quasi-helical arrangement of the myosin heads, whereas
when phosphorylated, it does not. Phosphorylation or ablation
of cMyBP-C thus have similar effects, abolishing or reducing
cMyBP-C’s stabilizing effect.
This interpretation is supported by the observation that both
the filaments from the CT-SD hearts and the filaments from the
cMyBP-C knockout mouse hearts (55, 56) retain significant ev-
idence of the 42.9-nm relaxed pseudohelical arrangement of the
myosin heads in some regions, and are variable in the extent of
disorder. The myosin heads are not completely disordered, as
might be expected if phosphorylation or ablation of cMyBP-C
directly caused an order-to-disorder transition in their arrange-
ment. Instead, the disorder is likely to be a result of the weak-
ening of the binding of the heads to the filament surface
predisposing them to become disordered by factors, such as in-
teractions with actin or other elements during the isolation
procedure or their binding to the carbon substrate during the
negative-staining procedure (71).
This interpretation is also consistent with our finding that the
diameters of the CT-SD filaments are similar to those of the
CT-SA filaments, and also to the diameters previously measured
for the filaments from the cMyBP-C knockout mouse and wild-
type hearts (55). Although the similarity in diameters was ini-
tially surprising, it is consistent with the possibility that many of
the myosin heads in the isolated CT-SD filaments and the
cMyBP-C knockout mouse filaments, although partially disor-
dered in their orientation, are still weakly bound to the filament
backbone. Within the lattice of the thick and thin filaments in
the intact muscle, however, this loss or weakening of binding of
the myosin heads to the thick filament would likely increase the
potential interaction of the myosin heads with the adjacent thin
filaments. This finding is suggested by X-ray diffraction evidence
indicating that when cMyBP-C is ablated or phosphorylated in
intact muscle, the myosin heads can extend out to a higher radius














(30, 72, 73), and by the acceleration of cardiac contractile ki-
netics observed when cMyBP-C is ablated or phosphorylated
(reviewed in ref. 48).
Relationship to Recent Studies of cMyBP-C Phosphorylation and
Ablation. Our results complement several recent studies using
techniques other than electron microscopy that also suggest that
cMyBP-C, when nonphosphorylated, helps to stabilize the re-
laxed, ordered arrangement of the myosin heads (57, 58).
Kampourakis et al. (57), using fluorescent probes on both tro-
ponin C and the myosin regulatory light chain, provided evidence
suggesting that in addition to activating the actin thin filament, the
nonphosphorylated N-terminal region of cMyBP-C may help to
maintain the thick filament in the relaxed “off-state.” They dem-
onstrated that the addition of the C1mC2 N-terminal fragment of
cMyBP-C to cardiac fibers in the presence of blebbistatin (74, 75)
induced a change in the orientation of the regulatory light chain
toward the off-state structure beyond that induced by blebbistatin
alone. This change in the orientation of the light chain clearly is
consistent with the idea that the N-terminal region of cMyBP-C,
when nonphosphorylated, helps to stabilize the relaxed off-state of
the myosin heads and their quasi-helical arrangement on the
vertebrate cardiac thick filament.
Also in support of this idea, McNamara et al. (58) examined
the role of cMyBP-C in regulating the population of heads in the
superrelaxed state (SRX) of cardiac myosin by comparing the
rate of single ATP turnover of myosin in cMyBP-C knockout
mouse hearts to that in wild-type hearts. In the SRX state (75;
for review, see ref. 76), the myosin heads are thought to be in the
off-state relaxed configuration suggested by the models of Wendt
et al. (77) and 3D reconstructions of both tarantula (78) and
vertebrate cardiac muscle thick filaments (56, 59, 60), and have
highly inhibited ATPase activity. Approximately 20% of cardiac
myosin in the wild-type mouse is in the SRX state and may
represent a reserve population of myosin heads that could
modulate cardiac contraction in response to factors such as
stress, changes in preload, and increased arterial pressures (76).
A significant reduction was reported in the proportion of heads
in the SRX state in homozygous cMyBP-C knockout mice
compared with that in the wild-type mouse hearts (58). Because
in the SRX state the myosin heads are thought to be bound in a
highly ordered arrangement to the filament backbone, the results
were interpreted as supporting the proposal that cMyBP-C sta-
bilizes this arrangement and that the loss of cMyBP-C results in
an untethering of the heads.
The results of these two studies appear to be consistent with our
earlier results by electron microscopy showing that the loss of
cMyBP-C is associated with an increased tendency for the relaxed
ordered myosin head array to become disordered (55, 56). These
results also complement our structural results here for the cMyBP-C
phosphomimetic mouse hearts. Because ablation or PKA phos-
phorylation of cMyBP-C appear to have similar effects on contrac-
tility (reviewed in ref. 48), our finding that the fully phosphorylated
state of cMyBP-C in the CT-SDmouse hearts results in an increased
tendency toward disorder of the myosin heads complements the
results of McNamara et al. (58) in demonstrating the similarity of
mechanisms by which ablation and phosphorylation of cMyBP-C
confer enhanced cardiac contractility.
Our studies, as well as these other recent studies, do not in any
way negate evidence that binding of cMyBP-C to the thin filament
contributes to the mechanism for regulation by cMyBP-C, but in-
stead support the increasing consensus that regulation of myocar-
dial contractility involves a mechanism in which both the binding of
cMyBP-C to the myosin head/S2 and to F-actin in the thin filament
are modulated by the phosphorylation state of cMyBP-C.
Conclusions. Comparison by electron microscopy of the structure
of thick filaments isolated from cMyBP-C phospho-deficient
(CT-SA) and phospho-mimetic (CT-SD) mouse hearts supports
the conclusion that cMyBP-C, when nonphosphorylated, acts to
stabilize the highly ordered off-state conformation of the myosin
heads on the thick filament, whereas phosphorylation of cMyBP-
C weakens this stabilization, predisposing the myosin heads to
disorder and increasing the probability of their interacting with
the thin filament.
Materials and Methods
Transgenic CT-SA and CT-SD Mouse Hearts and Wild-Type Hearts. The trans-
genic CT-SA [cMyBP-C(t3SA)] mice and CT-SD mice [cMyBP-C(t3SD)] (29) were
bred and maintained at the University of Wisconsin (UW) School of Medicine
and Public Health, whereas the wild-type BALB/c mice were maintained at
the University of Puerto Rico. As previously reported (9, 29, 31), the CT-SA
mice have substitution of alanine residues for serine residues Ser273, Ser282,
and Ser302 in the m-domain of the cMyBP-C expressed in their hearts. The
nonphosphorylatable alanine replacements in the cMyBP-C should mimic the
nonphosphorylated state of the cMyBP-C. In the CT-SD mice, these serines in
the m-domain were similarly replaced with aspartic acid to mimic the fully
phosphorylated state of the cMyBP-C in the hearts of the mice (30, 31).
Three-month-old male and female mice were used in the studies. Following
Institutional Animal Care and Use Committee-approved killing procedures at
the UW School of Medicine and Public Health, hearts from both the CT-SA
and the CT-SD mice were dissected from the animals, sliced in half, and
placed in an EGTA-Mincing solution (100 mM NaCl, 2.5 mM EGTA, 5 mM
MgAc, 1 mM DTT in 7 mM phosphate buffer, pH 7.0) and flash-frozen in
liquid nitrogen. The flash-frozen hearts on dry ice were shipped by over-
night express to the University of Puerto Rico and either immediately used
to prepare thick filament suspensions or stored at −80 °C until used. No
differences were seen between the immediately processed hearts and those
stored at −80 °C. The wild-type BALB/c mice were killed following In-
stitutional Animal Care and Use Committee-approved procedures at the
University of Puerto Rico Medical School. Both male and female wild-type
mice were used. Typically, two hearts from the CT-SA, CT-SD, and wild-type
mice were used for each filament preparation. Four separate replica isola-
tions of filaments from the CT-SA and CT-SD hearts were performed, thus a
total of 16 transgenic mice were used.
Isolation of Thick Filament Suspensions. Suspensions of thick filaments from the
CT-SA and CT-SDmouse hearts were isolated, as previously described formouse
(55) and zebrafish cardiac thick filaments (59). In initial experiments, thick
filaments from wild-type hearts were isolated in parallel by the same pro-
cedure for comparison and to ensure that the isolation procedure was working
as previously described (55, 59). In brief, small fiber bundles of the hearts,
rinsed with three to four changes of the mincing solution (1 h each), were left
overnight at 4 °C, and the following morning incubated for 30 min at room
temperature (∼25 °C) with slow stirring in a relaxing solution composed of
EGTA-mincing solution containing 2.5 mM ATP, 10 mM creatine phosphate,
and a proteolytic inhibitor mixture comprised of five components: N-p-tosyl-L-
phenylalanine chloromethyl ketone, leupeptin, aprotinin, pepstatin A, and
trypsin inhibitor, each at a final concentration of 0.004 mg/mL, at pH 6.8.
Separation of the thick filaments was performed using the previously de-
scribed elastase procedure for cardiac tissue (59, 60), with elastase and trypsin
inhibitor each at a final concentration of 0.44 mg/mL. The supernatant con-
taining the thick filaments was used to prepare electron microscopy grids. As
explained in the Discussion, inhibitors of regulatory light chain were not used
because the CT-SA and CT-SD hearts have similar in vivo basal levels of phos-
phorylation (29, 31) and are expected to be unphosphorylated or minimally
phosphorylated with the long incubation times and low calcium levels in-
volved in the isolation procedure (68).
Negative Staining and Electron Microscopy. Negative staining was performed
with 1% uranyl acetate, as previously described (55, 59, 60). All solutions
were at 25 °C to avoid the disordering of the filaments which can occur at
temperatures less than 15 °C (55, 59, 60). Electron microscopy was performed
as previously described (55) at 80 kV with a JEOL 1200EXII electron micro-
scope with an AMT HR60 high-resolution digital CCD camera (2K × 2K).
Magnification was calibrated using the 42.9-nm axial periodicity of the fil-
aments as a standard.
Assessment of Filament Helical Order. The thick filament periodicity was
assessed both visually and by calculation of Fourier transforms in 2,048 ×
2,048 pixel arrays as previously described (55, 61–63). The images were
straightened, rescaled, and rotated as necessary to ensure that the helical
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layer lines fell on the sampled lines by sizing the filament images to be
equivalent to thirty 42.9-nm axial repeats per 2,048 pixels (55, 61–63), which
is equivalent to a sampling spacing of ∼0.63 nm per pixel. Assessment of the
filament helical order was based upon the number, sharpness, and strength
of the layer lines in the transform. The radial extent of periodic information
along the first layer line and other periodicities in the transforms were cal-
culated relative to the spacings of the 14.29-nm−1 and 7.15-nm−1 meridional
reflections on the third and sixth layer lines.
Measurement of Filament Diameters. The diameters of both the CT-SA and CT-
SD filaments were measured in ImageJ. Because the actual magnification can
vary by up to 5% or more from that indicated by the electron microscope, the
42.9-nm axial periodicity of the filaments was used as an internal standard of
magnification. For each micrograph, a filament that appeared to retain at
least some evidence of the 42.9-nm axial repeat was selected, straightened,
and a Fourier transform performed. The layer line spacing was measured
based upon the meridional reflections on the third and sixth layer lines. This
value was used to calculate a scaling factor that was applied to the mi-
crograph to ensure that the spacing of the layer lines in the transforms from
the filaments was exactly 30 pixels. The straightened images of the fila-
ments from the micrograph were displayed horizontally, and the maximum
diameter of the filament was measured using a rectangular box whose
longitudinal edges ran along the outer tips of the myosin heads in regions
∼one repeat (42.9 nm) in length along the filament. The diameter in
nanometers of each of the measured regions was calculated by simple
proportion relative to the spacing in pixels of the 42.9-nm axial repeat,
and a mean and SD of all of the measured values for the CT-SA and CT-SD
filaments calculated.
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